+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Correlation between Thrombolysis in Myocardial Infarction (TIMI) Risk Scores and Electrocardiographic Changes, but Not Biochemical Markers, in Non-ST Segment Elevation Myocardial Infarction and other Acute Coronary Syndromes



Correlation between Thrombolysis in Myocardial Infarction (TIMI) Risk Scores and Electrocardiographic Changes, but Not Biochemical Markers, in Non-ST Segment Elevation Myocardial Infarction and other Acute Coronary Syndromes



Clinical Science 106(S50): 3p.3-4p




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063252997

Download citation: RISBibTeXText

DOI: 10.1042/cs106003pb


Related references

Correlation between thrombolysis in myocardial infarction risk scores and electrocardiographic changes, but not biochemical markers, in non-ST segment elevation myocardial infarction and other acute coronary syndromes. Clinical Science (London) 106(Suppl. 50): 3P-4P, 2004

Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores. Journal of Invasive Cardiology 15(9): 502-506, 2003

The relationship between TIMI (thrombolysis in myocardial infarction) risk score and efficacy of conservative or interventional strategy in patients with non-ST-segment elevation acute coronary syndromes. Zhonghua Xinxueguanbing Zazhi 34(11): 1001-1004, 2006

The relationship between TIMI (thrombolysis in myocardial infarction) risk score and efficacy of conservative or interventional strategy in patients with non-ST-segment elevation acute coronary syndromes. Zhonghua Xin Xue Guan Bing Za Zhi 34(11): 1001-1004, 2006

Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study. Journal of the American College of Cardiology 54(14): 1271-1279, 2009

Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). Journal of the American College of Cardiology 63(16): 1644-1653, 2014

Acute ischemic heart disease - Global outcomes of ST-elevation myocardial infarction: Comparisons of the enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25) registry and trial. American Heart Journal 154(1): 54-60, 2007

Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial. American Heart Journal 154(1): 54-61, 2007

B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial. Journal of the American College of Cardiology 55(12): 1189-1196, 2010

The role of thrombolysis in myocardial infarction (TIMI)risk score in prognosis prediction in senior patient with acute coronary syndromes without ST elevation. Zhonghua Yi Xue Za Zhi 84(13): 1103-1104, 2004

Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30). American Heart Journal 152(4): 756-761, 2006

Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). Journal of the American College of Cardiology 61(18): 1853-1859, 2013

Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28. American Heart Journal 159(6): 964-971.E1, 2010

Coronary Plaque Characteristics Associated With Reduced TIMI (Thrombolysis in Myocardial Infarction) Flow Grade in Patients With ST-Segment-Elevation Myocardial Infarction: A Combined Optical Coherence Tomography and Intravascular Ultrasound Study. Circulation. Cardiovascular Interventions 9(9):, 2016

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial. American Heart Journal 154(6): 1078-84 1084.E1, 2007